Health-related quality of life outcomes associated with zanubrutinib versus ibrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma: results from the ALPINE Trial

Tam, C. S., Lamanna, N., O’Brien, S. M., Qiu, L., Yang, K., Barnes, G., Wu, K., Salmi, T., & Brown, J. R. (2023). Health-related quality of life outcomes associated with zanubrutinib versus ibrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma: results from the ALPINE Trial. Current Medical Research and Opinion, 39(11), 1497–1503. https://doi.org/10.1080/03007995.2023.2262378

Authors:

Constantine S. Tam

Nicole Lamanna

Susan O’Brien

Lugui Qiu

Keri Yang

Gisoo Barnes

Ken Wu

Tommi Salmi

Jennifer R. Brown

Affiliated Authors:

Nicole Lamanna